The well-known drug tamoxifen could exploit a weakness in the physical ‘scaffolds’ around tumours, according to research led by Imperial.
The report’s authors, led by Imperial College London, say that following further research, the drug might in future be repurposed to help treat pancreatic cancer as well. Read more . . .